Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael S Phillips

Showing results (41-50 of 55) with videos related to

Pageof 6
Sort By:
European Journal of Human Genetics : EJHG|October 30, 2024
Characterization of Y chromosome diversity in newfoundland and labrador: evidence for a structured founding populationHeather Zurel, Claude Bhérer, Ryan Batten, et al.
Nature Genetics|November 10, 2009
Genetic variants in TPMT and COMT are associated with hearing loss in children receiving cisplatin chemotherapyColin J D Ross, Hagit Katzov-Eckert, Marie-Pierre Dubé, et al.
Circulation. Cardiovascular Genetics|September 13, 2014
CKM and LILRB5 are associated with serum levels of creatine kinaseMarie-Pierre Dubé, Rosa Zetler, Amina Barhdadi, et al.
Infection Control and Hospital Epidemiology|August 8, 2012
Central line-associated bloodstream infection surveillance outside the intensive care unit: a multicenter surveyCrystal H Son, Titus L Daniels, Janet A Eagan, et al.
Clinical Pharmacology and Therapeutics|March 1, 2005
beta-Adrenergic receptor polymorphisms and responses during titration of metoprolol controlled release/extended release in heart failureSteven G Terra, Daniel F Pauly, Craig R Lee, et al.
Communications Biology|April 28, 2023
The Newfoundland and Labrador mosaic founder population descends from an Irish and British diaspora from 300 years agoEdmund Gilbert, Heather Zurel, Margaret E MacMillan, et al.
Clinical Pharmacology and Therapeutics|September 5, 2023
PharmVar Tutorial on CYP2D6 Structural Variation Testing and Recommendations on ReportingAmy J Turner, Charity Nofziger, Bronwyn E Ramey, et al.
American Journal of Human Genetics|October 19, 2010
De novo mutations in FOXP1 in cases with intellectual disability, autism, and language impairmentFadi F Hamdan, Hussein Daoud, Daniel Rochefort, et al.
Nature Biotechnology|September 10, 2003
Large-scale genotyping of complex DNAGiulia C Kennedy, Hajime Matsuzaki, Shoulian Dong, et al.
Pharmacogenomics|April 28, 2018
A prospective study of the impact of AGTR1 A1166C on the effects of candesartan in patients with heart failureSimon de Denus, Marie-Pierre Dubé, René Fouodjio, et al.
Pageof 6

Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
European Journal of Human Genetics : EJHG|October 30, 2024
Characterization of Y chromosome diversity in newfoundland and labrador: evidence for a structured founding populationHeather Zurel, Claude Bhérer, Ryan Batten, et al.
Nature Genetics|November 10, 2009
Genetic variants in TPMT and COMT are associated with hearing loss in children receiving cisplatin chemotherapyColin J D Ross, Hagit Katzov-Eckert, Marie-Pierre Dubé, et al.
Circulation. Cardiovascular Genetics|September 13, 2014
CKM and LILRB5 are associated with serum levels of creatine kinaseMarie-Pierre Dubé, Rosa Zetler, Amina Barhdadi, et al.
Infection Control and Hospital Epidemiology|August 8, 2012
Central line-associated bloodstream infection surveillance outside the intensive care unit: a multicenter surveyCrystal H Son, Titus L Daniels, Janet A Eagan, et al.
Clinical Pharmacology and Therapeutics|March 1, 2005
beta-Adrenergic receptor polymorphisms and responses during titration of metoprolol controlled release/extended release in heart failureSteven G Terra, Daniel F Pauly, Craig R Lee, et al.
Communications Biology|April 28, 2023
The Newfoundland and Labrador mosaic founder population descends from an Irish and British diaspora from 300 years agoEdmund Gilbert, Heather Zurel, Margaret E MacMillan, et al.
Clinical Pharmacology and Therapeutics|September 5, 2023
PharmVar Tutorial on CYP2D6 Structural Variation Testing and Recommendations on ReportingAmy J Turner, Charity Nofziger, Bronwyn E Ramey, et al.
American Journal of Human Genetics|October 19, 2010
De novo mutations in FOXP1 in cases with intellectual disability, autism, and language impairmentFadi F Hamdan, Hussein Daoud, Daniel Rochefort, et al.
Nature Biotechnology|September 10, 2003
Large-scale genotyping of complex DNAGiulia C Kennedy, Hajime Matsuzaki, Shoulian Dong, et al.
Pharmacogenomics|April 28, 2018
A prospective study of the impact of AGTR1 A1166C on the effects of candesartan in patients with heart failureSimon de Denus, Marie-Pierre Dubé, René Fouodjio, et al.
Pageof 6